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ABSTRACT
Objective: The objective of this investigation was to study the effect of enteral/oral glutamine supplementation in patients following abdominal 
surgery on plasma glutamine levels, rate of infection, and length of hospitalization (LOH).
Methods: A randomized control trial was used, and the patients were randomly divided into two groups, namely experimental and control with 
30 participants each. Glutamine supplement (0.5 g/kg) was administered (oral and enteral) to the experimental group for 5 days post-surgery 
immediately after the feeding began. The study was conducted in ESIC hospital, Chennai, India.
Results: The incidence of infection in the control group was found to be almost twice that in the experimental group considering the role of glutamine 
in combating infection. Furthermore, the LOH was found to be slightly higher in the control group as compared to the experimental group.
Conclusion: This study has provided evidence that the supplementation of enteral glutamine in post-operative patients decreases the incidence of 
post-surgical infection, shortening of hospital stay and reduction in the overall hospital costs.
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INTRODUCTION
“Protein energy malnutrition” a major problem in the management of 
post-operative patients was long recognized by Hiram, an American 
surgeon way back in 1936, as he observed that weight loss was as 
significant predictor of surgical risk among his patients suffering from 
peptic ulcer disease [1]. According to “gut origin of sepsis” hypothesis 
the leaky gut is an essential factor in developing septic complications 
with the concept of bacterial translocation as demonstrated in vitro 
and in vivo studies [2]. In addition, nutritional depletion is associated 
with increased intestinal permeability and a decrease in villous 
height [3]. Post-operative nutritional supplementation has been known 
to improve the quality of life, nutritional status, and morbidity of 
patients [4]. Hence, “malnutrition matters” and “nutrition is the cutting 
edge in surgery [5].” Enteral nutrition has been known to bring about 
reduction in infectious complications in post major abdominal surgery 
[6]. Previous systematic reviews and meta-analysis have suggested that 
immune nutrition in critically ill have been associated with reduced 
hospital stay, infection rate, and inflammatory response [7]. Any 
catabolic stressful condition results in 50% loss of glutamine from the 
muscles and it is of utmost importance to deliver adequate amounts of 
glutamine to maintain the integrity of intestinal mucosa, to preserve 
the muscle glutamine pool and to improve overall nitrogen economy 
during conditions of stress [8]. Glutamine is known to be a precursor 
of protein synthesis and the mucosal and the immune cells in the body 
utilize this particular immunonutrient as an energy source in almost 
all the tissues. Furthermore, glutamine is involved in a large number 
of metabolic pathways. One of the major procedures which result in 
severe depletion of glutamine from the skeletal muscles, bringing 
about muscle loss immunosuppression thus resulting in increased 
risk for post-operative infection and sepsis is surgery. Various studies 
have indicated that glutamine supplementation in post-operative 
patients bring about improvement in their clinical outcome and also 
their intestinal permeability [9-12]. However, a conclusive data on this 
aspect have not been explored much in India. As noted in the review 
of Jan Wernerman, the recommendation from ESPEN and ASPEN/
SCCM is to add intravenous (IV) glutamine supplementation when 
total parenteral nutrition (TPN) is given to critically ill patients. In 
all guidelines, this is given a level A recommendation. Meta-analyses 
have identified a dose of 0.3-0.5 g/kg/d in parenteral nutrition to 
normalize plasma glutamine concentration in almost all critically 
ill patients. However, no sufficient data have been obtained on the 
enteral glutamine requirement in post-surgery patients. Hence, this 
study attempts to understand the effect of glutamine supplementation 
in patients following abdominal surgery on plasma glutamine levels, 
length of hospitalization (LOH), and rate of infection.
METHODS
This was a randomized controlled trial wherein 30 participants 
following abdominal surgery belonging to the age group of 20-55 years 
were recruited from the surgery ward of ESIC hospital, Ayanavaram 
using purposive sampling technique. The patient characteristics are 
given in Table 1.
Exclusion criteria
Patients with comorbidities such as Type I diabetes and Type II 
diabetes on insulin management, renal diseases (creatinine 
concentration >2.5 mg/dl), cardiac disorders (Class III or IV), hepatic 
disease (total bilirubin concentration >3 mg/dl), autoimmune diseases, 
chronic use of steroids (30 mg or more for more than a month), 
chronic obstructive pulmonary disease (partial pressure of carbon 
dioxide>375 kPa or 50 mmHg) and pregnant women.
Withdrawal criteria
Non-compliance with the blood test.
Ethical approval
The study was approved by the Independent Ethics Committee at 
Vels University, Chennai. 30 consenting participants were randomly 
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assigned into two groups preoperatively namely: Control (diet) group 
and experimental (diet+supplement) group.
Dietary management
Gastrostomy and jejunostomy tubes were placed during the surgery for 
post-operative nutrition support. However, 10% of the participants were 
given oral feeds directly in post-surgery as they showed tolerance for the 
same. The nutrition formula of both the groups was closely matched for 
energy and protein content. Feeding for either group began at strength of 
1200 kcal/day further advancing it on a daily basis toward the goal caloric 
requirement of 35-40 kcal/kg body weight. Goal nutrition also provided 
1.5 g protein/kg body weight/day. The experimental group was given 
0.5 g glutamine/day for 5 days. Tube feeding tolerance for the participants 
on the same was done by daily recording of nausea, vomiting, or diarrhea.
Glutamine supplement
Meta gluta ZS glutamine granules were used in the study. Each sachet 
contained 10 g glutamine. The supplement was weighed as per the 
dosage requirement of 0.5 g/kg body weight for each patient using a 
digital weighing scale.
Route of administration
The supplement was given in divided doses throughout the day. 10 g 
of the glutamine from the supplement (Meta gluta ZS) was mixed in 
180 ml of water and given orally and enterally for the patients where 
oral feed was not possible.
Mode of study
The study protocol was divided into 4 sections:
1. Post-operative day 1 assessment of plasma glutamine levels
2. The primary study period of 5 post-operative enteral feeding days
3. Reassessment of plasma glutamine levels on day 6 of feeding
4. Follow-up and tracking the incidence of infection and LOH till the 
patient was discharged.
Statistical analysis
Continuous data were summarized as mean±standard deviation. 
Independent t-test was used to compare the two groups with respect 
to body mass index, age, calories, and proteins received by day 5 and 
LOH. The difference in incidence of infection between the two groups 
was analyzed using the Chi-square test and the differences in plasma 
glutamine levels on day 6 were analyzed using independent t-test. 
Paired t-test was used to compare the plasma glutamine levels within 
the group pre- and post-supplementation
RESULTS AND DISCUSSION
A total of 30 patients following abdominal surgery were recruited in 
this study and were randomly selected.
The patients were randomly divided into two groups, namely control 
and experimental groups. The participants mainly belonged to the 
lower socioeconomic class. Patient characteristics are listed in Table 1. 
The nutrition formulas of both the groups were closely matched for 
energy and protein content. Feeding for either group began at strength 
of 1200 kcal/day further advancing it on a daily basis toward the goal 
caloric requirement of 35-40 kcal/kg body weight. Goal nutrition also 
provided 1.2-1.5 g protein/kg body weight/day. The caloric and protein 
distribution achieved as on day 5 have been listed in Table 2. The 
surgical procedures followed by both the groups are given in Fig. 1.
LOH
The average LOH was 19.8±13.1 days in the experimental group 
and 25.13±15.13 days in the control group. The LOH with glutamine 
supplementation was significantly shortened in an experiment with a 
p=0.05.
Incidence of infection
About 53.3% of the participants in the control group were reported to 
have secondary infection post-surgery as compared to only 26.66% in 
the experimental group as shown in Table 3. The differences in the rate 
of infection among the two groups were significantly different with a 
p<0.05 as seen in Table 3. Nutrition support has been widely used in 
the area of surgery, where the benefit on patients’ prognosis is evident. 
Surgical site infections and wound and tissue dehiscence are well 
known post-operative complications in gastrointestinal surgery. Thus, 
an appropriate and feasible nutrition support strategy is necessary and 
beneficial for patients’ prognosis. Several researchers have analyzed 
the role of glutamine post-surgery. Dechelotte et al. evaluated the 
absorption and metabolic effects of enterally administered glutamine 
using stable isotope methods in healthy subjects. Plasma glutamine 
showed a dose-dependent increase and they concluded that glutamine 
is effectively absorbed by the jejunum. A meta-analysis including 
9 randomized, controlled clinical trials, with a total of 373 patients 
undergoing abdominal surgery, concluded that administration of 
parenteral nutrition supplemented with glutamine (20-40 g/day) has 
a beneficial effect on nitrogen balance, reduces hospital length of stay 
and infectious complications. Oguz conducted a study in post-operative 
patients with colorectal cancer, where enteral nutrition versus enteral 
nutrition supplemented with parenteral glutamine was administered, 
in a total of 109 patients, concluding that glutamine supplements 
reduce the number of post-operative complications and hospital stay. 





Age 38±13.45 years 39.4±12.33 years
BMI 23.3±6.76 kg/m2 21.7±2.98 kg/m2
Male 8 10
Female 7 5
n (sample size) 15 15
BMI: Body mass index









1602±296.70 1585.33±236.57 0.042 NS
Mean protein (g/d) 65.26±10.25 61.93±14.39 0.223 NS
NS: Not significant
Fig. 1: Types of surgery in two groups
Table 3: Hospitalization and incidence of infection in control 
versus experimental group









*Significant at 5% level. LOH: Length of hospitalization
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Kumar compared in patients with peritonitis and abdominal injuries the 
administration of enteral glutamine (45 g/day) versus conventional EN 
without finding benefits in the glutamine group. Jan Wernerman 
mentioned that in post-operative patients, a daily IV glutamine dose of 
20 g attenuates the decrease otherwise seen in skeletal muscle. This 
dose was originally chosen from a calculation of the decline in the free 
glutamine pool. Researchers in the ASPEN position paper on parenteral 
nutrition for glutamine supplementation have stated the probability 
of parenteral nutrition glutamine supplementation being better over 
enteral administration of glutamine in surgical and critically ill patients. 
However, parenteral nutrition generally proves to be very expensive 
and is not affordable for the lower socioeconomic group. Hence keeping 
this in mind in this study, oral glutamine supplements were used 
at a dosage of 0.5 g/kg body weight for a period of 5 days and it was 
observed that plasma glutamine levels on day 6 of feeding showed a 
significant increase as compared to day 0 in both the groups.
Proteins 1.2-1.5 g protein/kg body weight was supplied through the diet 
as protein consumption also has a direct correlation with the glutamine 
levels. However as shown in Table 3, the increment was significantly 
more in the experimental group as compared to the control group. 
Similar finding was observed in a study done on patients receiving IV 
glutamine supplementation following elective abdominal surgery. The 
incidence of infection in the control group was found to be almost twice 
that in the experimental group (53.3% vs. 26.6%) considering the 
role of glutamine in combating infection. Furthermore, the LOH was 
found to be significantly higher in the control group as compared to 
the experimental group (25.13±15.13 day’s vs. 19.8±13.1 days). In this 
study, due to limitations in the size of the samples, a great significant 
value could not be obtained. A similar study done on burn patients in 
China displayed normalization of the plasma glutamine levels after oral 
glutamine supplementation (0.5 g/kg body weight) for 14 days.
CONCLUSION
Hence, the fact that glutamine does help in reducing the rate of infection 
cannot be denied. As observed in this study, the experimental group did 
far better than the control in terms of LOH and incidence of infection. 
However since no such guidelines for oral glutamine supplementation 
in patients following abdominal surgery is available, we need to confirm 
this finding with larger population groups.
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